As of June 19, 2025, Guided Therapeutics Inc (GTHP) reports a Gross Margin of 28.57%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Guided Therapeutics Inc's Gross Margin
Over recent years, Guided Therapeutics Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 28.57% |
| 2023-12-31 | 36.73% |
| 2022-12-31 | -700.00% |
| 2021-12-31 | 25.00% |
| 2020-12-31 | 140.00% |
This slight downward trend highlights how Guided Therapeutics Inc manages its operational efficiency and pricing power over time.
Comparing Guided Therapeutics Inc's Gross Margin to Peers
To better understand Guided Therapeutics Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Guided Therapeutics Inc (GTHP) | 28.57% |
| Imagin Medical Inc (IME.CN) | 7775.20% |
| Bionoid Pharma Inc (BINP) | 7775.20% |
| THC Therapeutics Inc (THCT) | 7775.20% |
| Stock Trend Capital Inc (PUMP.CN) | 100.00% |
| Quantrx Biomedical Corp (QTXB) | 100.00% |
Compared to its competitors, Guided Therapeutics Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.